[Federal Register: June 27, 2003 (Volume 68, Number 124)]
[Notices]
[Page 38582]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27jn03-145]
[[Page 38582]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[DEA-217N]
RIN 1117-AA60
Electronic Orders for Controlled Substances: Notice of Meeting
AGENCY: Drug Enforcement Administration (DEA), Justice.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA) will hold a public
meeting to provide technical details regarding the use of digital
signatures and Public Key Infrastructure (PKI) technology within DEA's
proposed system for electronic orders for Schedule I and II controlled
substances.
DATES: Thursday, July 24, 2003.
ADDRESSES: Marriott Residence Inn, 550 Army-Navy Drive, Arlington,
Virginia 22202. The meeting will be held from 9 a.m. until 4:30 p.m.
Persons wishing to attend this meeting, space permitting, must
provide attendee information to the Liaison and Policy Section, Office
of Diversion Control, Drug Enforcement Administration, via facsimile at
(202) 307-8570 as specified below. Persons wishing to attend the
meeting must provide this information to the Liaison and Policy Section
no later than July 21, 2003.
FOR FURTHER INFORMATION CONTACT: Patricia M. Good, Chief, Liaison and
Policy Section, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Telephone (202) 307-7297.
SUPPLEMENTARY INFORMATION:
Background
In a separate Notice of Proposed Rulemaking published in today's
Federal Register, the Drug Enforcement Administration (DEA) is
proposing regulations regarding the electronic transmission of Schedule
I and II controlled substances orders from purchasers (DEA-registered
distributors, pharmacies and practitioners) to suppliers (DEA-
registered manufacturers and distributors) and the electronic retention
of records pertaining to those orders. DEA is proposing that these
electronic orders be conducted using Public Key Infrastructure (PKI)
technology, including the use of digital certificates provided by the
DEA root Certification Authority.
This meeting is being held to provide information to interested
persons including systems vendors and developers regarding industry's
development of electronic systems which conform to the standards and
regulations DEA is proposing. Persons interested in learning about the
development of such PKI-based systems using DEA's standards may attend
this meeting, so long as space permits.
Background and Supporting Documents
Supporting documents regarding DEA's system to permit the
electronic transmission of Schedule I and II controlled substances
orders and the electronic retention of records pertaining to those
orders, including the Certificate Policy, Certificate Profile,
enrollment documents, PKI test suite and other pertinent materials may
be found within the Electronic Commerce Initiatives/CSOS section on the
Diversion Control Program Web site: http://www.deadiversion.usdoj.gov/ecomm/index.html
.
Meeting Registration
Persons wishing to attend this meeting must provide the following
information to the Liaison and Policy Section, Office of Diversion
Control, Drug Enforcement Administration, via facsimile at the number
listed above:
Name:------------------------------------------------------------------
Title:-----------------------------------------------------------------
Company/Organization:--------------------------------------------------
Address:---------------------------------------------------------------
Telephone:-------------------------------------------------------------
E-mail address:--------------------------------------------------------
Dated: June 20, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control.
[FR Doc. 03-16083 Filed 6-26-03; 8:45 am]
BILLING CODE 4410-09-P